Ad blocking detected

Thank you for visiting We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

MustGrow Biologics Corp. (C:MGRO)

Business Focus: Biotechnology & Medical Research

INK Edge Outlook

Mostly sunny as of January 01, 2021
For the latest outlook, get the company report

Insider Chart - Past 6 Months

INK Ultra Money Free

Insider Filings

Latest 10 SEDI filings for MGRO within the last 6 months
See all filings within the past 6 months

Company News

Jan 14, 2021 07:02 ET
MustGrow Confirms Proceeds of C$1.5 Million from Warrant Exercise
Saskatoon, Saskatchewan--(Newsfile Corp. - January 14, 2021) -  MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company", "MustGrow") is pleased to announce that it has received over C$1.5 million from the exercise of approximately 3.2 million common share purchase warrants at an average weighted exercise price of C$0.48 per share. The Company intends to use the proceeds of the warrant exercise to advance its organic mustard plant-based crop protection technologies and for general working capital purposes. MustGrow has harnessed the mustard seed's natural defense mechanism to control diseases, pests, and weeds with a natural food-grade biopesticide.
Read full article
Dec 14, 2020 07:02 ET
MustGrow Appoints Impossible Foods Executive to Board
Saskatoon, Saskatchewan--(Newsfile Corp. - December 14, 2020) - MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company", "MustGrow") is pleased to announce the appointment of Mr. David M. Borecky, Vice President and Chief Accounting Officer of Impossible Foods to its Board of Directors. David will leverage his extensive global relationships in the plant-based innovation community to accelerate and raise awareness of MustGrow's remarkably safe and effective plant-based crop protection technologies.
Read full article
See more news stories

Valuation Ratios

Price to Sales - TTM
Price to Book - most recent quarter
Price to Cash Flow per share - TTM
Price to Free Cash Flow per share - TTM
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Dec 31, 2020199,897-205,055
Dec 15, 2020404,952301,373
Nov 30, 2020103,57978,857
See Short Report

Business Summary

Sector:  Healthcare Industry:  Biotechnology & Medical Research

MustGrow Biologics Corp. is a Canada-based agricultural company developing and commercializing a portfolio of natural biopesticides and biofertilizers for the cannabis industry. Targeting the fruit, vegetable, turf, ornamentals and cannabis industries, the Company has designed a solution that uses the mustard seed's natural defense mechanisms to protect plants from pests and diseases.

See business summary



Search (past week) for $MGRO.CA